DLX5 and lymphoma: To determine if β-catenin plays a role in the survival of lymphoma cells from Lck-Dlx5;Lck-MyrAkt2 mice, the cells were treated with PFK118-310, an inhibitor that interferes with β-catenin’s binding to Tcf/Lef.